58 related articles for article (PubMed ID: 22541092)
1. [SUDHL-4 cell culture in vitro and establishment of mouse tumor model].
Wang YQ; Huo HJ; Lu LL; Xu M; Zhu JP; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):329-34. PubMed ID: 22541092
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and characterization of a nude mice model of human diffuse large B-cell lymphoma].
Yu BH; Zhou XY; Zhang TC; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):246-50. PubMed ID: 21615998
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between Chemotactic Factor CCL5 and Diabet-associated Diffuse Large B Cell Lymphoma].
Zhang JC; Liu FR; Hu HX; He F; Tu Y; Wei B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1325-30. PubMed ID: 26524031
[TBL] [Abstract][Full Text] [Related]
4. [Immuno-characterization of mouse model similar to human diffuse large B cell lymphoma].
Liu F; Zhang G; Zhou XH; Liu J; Yue Y; Zhao T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):655-9. PubMed ID: 20561422
[TBL] [Abstract][Full Text] [Related]
5. The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma.
Zhu L; Xia C; Wu L; Zhang Y; Liu J; Chen Y; Liu J; Xiao Y; Nie K; Huang L; Qu N; Yu H
Cell Commun Signal; 2019 Aug; 17(1):92. PubMed ID: 31409422
[TBL] [Abstract][Full Text] [Related]
6. Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.
Cocco C; Di Carlo E; Zupo S; Canale S; Zorzoli A; Ribatti D; Morandi F; Ognio E; Airoldi I
Leukemia; 2012 Jun; 26(6):1365-74. PubMed ID: 22193967
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.
Chao CN; Huang YL; Lin MC; Fang CY; Shen CH; Chen PL; Wang M; Chang D; Tseng CE
J Transl Med; 2015 Jan; 13():29. PubMed ID: 25623859
[TBL] [Abstract][Full Text] [Related]
8. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
9. Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance.
Otsuka M; Yakushijin Y; Hamada M; Hato T; Yasukawa M; Fujita S
Br J Haematol; 2004 Nov; 127(4):416-24. PubMed ID: 15521918
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of a human esophageal carcinoma transplantation model with MUC1 high expression in nude mice].
Deng YJ; Rong TH; Zhou J; Song HF; Wang QJ; Huang LX; Chen SP; Li YQ; Xia JC
Ai Zheng; 2007 Jul; 26(7):693-7. PubMed ID: 17626742
[TBL] [Abstract][Full Text] [Related]
11. In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma.
Turturro F; Seth P; Link CJ
Clin Cancer Res; 2000 Jan; 6(1):185-92. PubMed ID: 10656449
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
Dias JNR; André AS; Aguiar SI; Ministro J; Oliveira J; Peleteiro MC; Rütgen B; Gano L; Correia JDG; Oliveira SS; Goncalves J; Gil S; Tavares L; Aires-da-Silva F
PLoS One; 2018; 13(12):e0208147. PubMed ID: 30592723
[TBL] [Abstract][Full Text] [Related]
13. Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.
Chang KC; Chen RY; Wang YC; Hung LY; Medeiros LJ; Chen YP; Chen TY; Yang JC; Chiang PM
Sci Rep; 2020 Dec; 10(1):21342. PubMed ID: 33288848
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5.
Zhang J; Luo J; Liu F; Wu D; Zhong Q; Zeng L; Wu Z; Zhao T; Wu L; Hao H
Mol Med Rep; 2014 Sep; 10(3):1231-6. PubMed ID: 24938715
[TBL] [Abstract][Full Text] [Related]
15. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma.
Bosch R; Moreno MJ; Dieguez-Gonzalez R; Céspedes MV; Gallardo A; Nomdedeu J; Pavón MA; Espinosa I; Mangues MA; Sierra J; Casanova I; Mangues R
Clin Exp Metastasis; 2012 Apr; 29(4):339-47. PubMed ID: 22262061
[TBL] [Abstract][Full Text] [Related]
17. Influence of corticosteroid treatment on CXCR4 expression in DLBCL.
Martin S; Viertl D; Janz A; Habringer S; Keller U; Schottelius M
EJNMMI Res; 2023 May; 13(1):40. PubMed ID: 37162652
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.
Yang G; Zhang Q; Kong Y; Xie B; Gao M; Tao Y; Xu H; Zhan F; Dai B; Shi J; Wu X
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):925-31. PubMed ID: 26358321
[TBL] [Abstract][Full Text] [Related]
20. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
